MEN1 and pancreatic neuroendocrine tumor: In NET G3, which is most frequently occurring in the pancreas (Coriat et al. 2016), most alterations were also seen in pancreatic primaries, including mutations in MEN1 (33%), ATRX (25%) and DAXX (25%; within the subgroup of pancreatic NET G3).